Vesicoureteric reflux and renal malformations: A developmental problem

Clinical Genetics

Volumn 69, Issue 2, 2006, Pages 105-117

  Murawski, I J ^a   Gupta, Indra R ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Genetics of VUR; Kidney development; Kidney malformation; Urinary tract development; Vesicoureteric reflux

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; MEMBRANE PROTEIN; PROTEIN RET; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RETINAL DEHYDROGENASE; RETINOIC ACID RECEPTOR; SLIT2 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2;

ARTICLE; CHILD HEALTH CARE; DATA ANALYSIS; DEVELOPMENTAL BIOLOGY; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; FAMILY STUDY; GENE DELETION; GENE DISRUPTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; INCIDENCE; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY MALFORMATION; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; TWINS; URETER; URINARY TRACT; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC HETEROGENEITY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; KIDNEY; URETER; VESICO-URETERAL REFLUX;

ERINACEIDAE;

EID: 33644849145     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00562.x     Document Type: Article

References (113)

1. Mak RH, Kuo HJ. Primary ureteral reflux: Emerging insights from molecular and genetic studies. Curr Opin Pediatr 2003: 15 (2): 181-185.
2. Burger RH, Smith C. Hereditary and familial vesicoureteral reflux. J Urol 1971: 106 (6): 845-851.
3. Chapman CJ, Bailey RR, Janus ED et al. Vesicoureteric reflux: segregation analysis. Am J Med Genet 1985: 20 (4): 577-584.
4. http://www.spitfire.emmes.com/study/ped/resources/annlrept2004.pdf, NAPRTCS Annual Report, 2004.
5. http://www.secure.cihi.ca/cihiweb/ dispPage.jsp?cw_page=PG_31_E&cw_topic=31&cw_rel=AR_5_E.CORR Annual Report - Dialysis and Renal Transplantation, 2001.
6. USA Collaborative study. Medical versus surgical treatment of primary vesicoureteral reflux: A prospective international reflux study in children. J Urol 1981: 125 (3): 277-283.
7. Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ 1994: 308 (6938): 1193-1196.
8. Craig JC, Irwig LM, Knight JF et al. Does treatment of vesicoureteric reflux in childhood prevent end-stage renal disease attributable to reflux nephropathy? Pediatrics 2000: 105 (6): 1236-1241.
9. Caione P, Villa M, Capozza N et al. Predictive risk factors for chronic renal failure in primary high-grade vesico-ureteric reflux. BJU Int 2004: 93 (9): 1309-1312.
10. Smellie J, Edwards D, Hunter N et al. Vesico-ureteric reflux and renal scarring. Kidney Int Suppl 1975: 4: S65-S72.
11. Hiraoka M, Hori C, Tsukahara H et al. Congenitally small kidneys with reflux as a common cause of nephropathy in boys. Kidney Int 1997: 52 (3): 811-816.
12. Risdon RA. The small scarred kidney in childhood. Pediatr Nephrol 1993: 7 (4): 361-364.
13. Najmaldin A, Burge DM, Atwell JD. Reflux nephropathy secondary to intrauterine vesicoureteric reflux. J Pediatr Surg 1990: 25 (4): 387-390.
14. Hinchliffe SA, Kreczy A, Ciftci AO et al. Focal and segmental glomerulosclerosis in children with reflux nephropathy. Pediatr Pathol 1994: 14 (2): 327-338.
15. Schultheiss D, Grunewald V, Jonas U. Urodynamics in the anatomical work of Leonardo da Vinci (1452-1519). World J Urol 1999: 17 (3): 137-143.
16. Polk HC Jr. Notes on galenic urology. Urol Surv 1965: 15: 2-6.
17. Tanagho EA, Pugh RC. The anatomy and function of the ureterovesical junction. Br J Urol 1963: 35: 151-165.
18. Gruber CM. A comparative study of the intra-vesical ureters (uretero-vesical valves) in man and in experimental animals. J Urol 1929: 21 (5): 567-581.
19. Tanagho EA, Guthrie TH, Lyon RP. The intravesical ureter in primary reflux. J Urol 1969: 101 (6): 824-832.
20. Vermillion CD, Heale WF. Position and configuration of the ureteral orifice and its relationship to renal scarring in adults. J Urol 1973: 109 (4): 579-584.
21. Batourina E, Choi C, Paragas N et al. Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat Genet 2002: 32 (1): 109-115.
22. Mackie GG, Stephens FD. Duplex kidneys: A correlation of renal dysplasia with position of the ureteral orifice. J Urol 1975: 114 (2): 274-280.
23. Schwarz RD, Stephens FD, Cussen LJ. The pathogenesis of renal dysplasia. II. The significance of lateral and medial ectopy of the ureteric orifice. Invest Urol 1981: 19 (2): 97-100.
24. Sainio K, Suvanto P, Davies J et al. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 1997: 124 (20): 4077-4087.
25. Moore MW, Klein RD, Farinas I et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996: 382 (6586): 76-79.
26. Schuchardt A, D'Agati V, Pachnis V et al. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 1996: 122 (6): 1919-1929.
27. Cacalano G, Farinas I, Wang LC et al. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 1998: 21 (1): 53-62.
28. Bouchard M. Transcriptional control of kidney development. Differentiation 2004: 72 (7): 295-306.
29. Brophy PD, Ostrom L, Lang KM et al. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 2001: 128 (23): 4747-4756.
30. Miyazaki Y, Oshima K, Fogo A et al. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 2000: 105 (7): 863-873.
31. Kume T, Deng K, Hogan BL. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 2000: 127 (7): 1387-1395.
32. Grieshammer U, Le M, Plump AS et al. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 2004: 6 (5): 709-717.
33. Basson MA, Akbulut S, Watson-Johnson J et al. Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 2005: 8 (2): 229-239.
34. Oshima K, Miyazaki Y, Brock JW III et al. Angiotensin type II receptor expression and ureteral budding. J Urol 2001: 166 (5): 1848-1852.
35. Batourina E, Tsai S, Lambert S et al. Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder. Nat Genet 2005: 37 (10): 1082-1089.
36. Stephens FD, Joske RA, Simmons RT. Megaureter with vesico-ureteric reflux in twins. Aust N Z J Surg 1955: 24 (3): 192-194.
37. Kerr DN, Pillai PM. Identical twins with identical vesicoureteric reflux: Chronic pyelonephritis in one. Br Med J (Clin Res Ed) 1983: 286 (6373): 1245-1246.
38. Mebust WK, Foret JD. Vesicoureteral reflux in identical twins. J Urol 1972: 108 (4): 635-636.
39. Tobenkin MI. Hereditary vesicoureteral reflux. South Med J 1964: 57: 139-147.
40. King LR. Vesicoureteral reflux: A radiographic sign common to multiple diseases JAMA 1972: 220 (6): 854.
41. Kaefer M, Curran M, Treves ST et al. Sibling vesicoureteral reflux in multiple gestation births. Pediatrics 2000: 105 (4 Pt 1): 800-804.
42. Uehling DT, Vlach RE, Pauli RM et al. Vesicoureteric reflux in sibships. Br J Urol 1992: 69 (5): 534-537.
43. Devriendt K, Groenen P, Van Esch H et al. Vesico-ureteral reflux: A genetic condition? Eur J Pediatr 1998: 157 (4): 265-271.
44. Pasch A, Hoefele J, Grimminger H et al. Multiple urinary tract malformations with likely recessive inheritance in a large Somalian kindred. Nephrol Dial Transplant 2004: 19 (12): 3172-3175.
45. Middleton GW, Howards SS, Gillenwater JY. Sex-linked familial reflux. J Urol 1975: 114 (1): 36-39.
46. Burger RH. Familial and hereditary vesicouretral reflux. Jama 1971: 216 (4): 680-681.
47. de Vargas A, Evans K, Ransley P et al. A family study of vesicoureteric reflux. J Med Genet 1978: 15 (2): 85-96.
48. Hutch JA. Theory of maturation of the intravesical ureter. J Urol 1961: 86: 534-538.
49. Jerkins GR, Noe HN. Familial vesicoureteral reflux: A prospective study. J Urol 1982: 128 (4): 774-778.
50. Noe HN. The long-term results of prospective sibling reflux screening. J Urol 1992: 148 (5 Pt 2): 1739-1742.
51. Bailey RR, Janus E, McLoughlin K et al. Familial and genetic data in reflux nephropathy. Contrib Nephrol 1984: 39: 40-51.
52. Bailey RR. Long-term follow-up of infants with gross vesico-ureteric reflux. Contrib Nephrol 1984: 39: 146-151.
53. Sengar DP, McLeish WA, Rashid A et al. Histocompatibility antigens in urinary tract infection and vesicoureteral reflux: A preliminary communication. Clin Nephrol 1978: 10 (4): 166-169.
54. Sengar DP, Rashid A, Wolfish NM. Familial urinary tract anomalies: association with the major histocompatibility complex in man. J Urol 1979: 121 (2): 194-197.
55. Mackintosh P, Almarhoos G, Heath DA. HLA linkage with familial vesicoureteral reflux and familial pelvi-ureteric junction obstruction. Tissue Antigens 1989: 34 (3): 185-189.
56. Torres VE, Moore SB, Kurtz SB et al. In search of marker for genetic susceptibility to reflux nephropathy. Clin Nephrol 1980: 14 (5): 217-222.
57. Sanyanusin P, Schimmenti LA, McNoe LA et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995: 9 (4): 358-364.
58. Schimmenti LA, Pierpont ME, Carpenter BL et al. Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies. Am J Med Genet 1995: 59 (2): 204-208.
59. Heimler A, Lieber E. Branchio-oto-renal syndrome: Reduced penetrance and variable expressivity in four generations of a large kindred. Am J Med Genet 1986: 25 (1): 15-27.
60. Ruf RG, Xu PX, Silvius D et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci USA 2004: 101 (21): 8090-8095.
61. Muroya K, Hasegawa T, Ito Y et al. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet 2001: 38 (6): 374-380.
62. Kolon TF, Gray CL, Sutherland RW et al. Upper urinary tract manifestations of the VACTERL association. J Urol 2000: 163 (6): 1949-1951.
63. Grisaru S, Ramage IJ, Rosenblum ND. Vesicoureteric reflux associated with renal dysplasia in the Wolf-Hirschhorn syndrome. Pediatr Nephrol 2000: 14 (2): 146-148.
64. Selicorni A, Sforzini C, Milani D et al. Anomalies of the kidney and urinary tract are common in de Lange syndrome. Am J Med Genet A 2005: 132 (4): 395-397.
65. Levy CM, Knudtzon J. Kallmann syndrome in two sisters with other developmental anomalies also affecting their father. Clin Genet 1993: 43 (1): 51-53.
66. Lipson AH, Yuille D, Angel M et al. Velocardiofacial (Shprintzen) syndrome: An important syndrome for the dysmorphologist to recognise. J Med Genet 1991: 28 (9): 596-604.
67. Chou IC, Tsai FJ, Yu MT et al. Smith-Magenis syndrome with bilateral vesicoureteral reflux: A case report. J Formos Med Assoc 2002: 101 (10): 726-728.
68. Donnenfeld AE, Schrager DS, Corson SL. Update on a family with hand-foot-genital syndrome: Hypospadias and urinary tract abnormalities in two boys from the fourth generation. Am J Med Genet 1992: 44 (4): 482-484.
69. Nanclares GP, Martinez F, Bilbao JR et al. A submicroscopic deletion of 11p13 associated with the WAGR syndrome. Clin Genet 2003: 63 (4): 319-322.
70. Choi KL, McNoe LA, French MC et al. Absence of PAX2 gene mutations in patients with primary familial vesicoureteric reflux. J Med Genet 1998: 35 (4): 338-339.
71. Jenkins D, Bitner-Glindzicz M, Malcolm S et al. De novo uroplakin 111a heterozygous mutations cause renal adysplasia leading to severe kidney failure. J Am Soc Nephrol 2005: 16 (7): 2141-2149.
72. Lu W, Peters R, Ferguson H et al. Disruption of ROBO2 is associated with vesicoureteral reflux. J Am Soc Nephrol 2004: 15: 32A.
73. Ohtomo Y, Nagaoka R, Kaneko K et al. Angiotensin converting enzyme gene polymorphism in primary vesicoureteral reflux. Pediatr Nephrol 2001: 16 (8): 648-652.
74. Rigoli L, Chimenz R, di Bella C et al. Angiotensin-converting enzyme and angiotensin type 2 receptor gene genotype distributions in Italian children with congenital uropathies. Pediatr Res 2004: 56 (6): 988-993.
75. Yoneda A, Oue T, Puri P. Angiotensin-converting enzyme genotype distribution in familial vesicoureteral reflux. Pediatr Surg Int 2001: 17 (4): 308-311.
76. Park HW, Koo JW, Kim JS et al. Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children. Nephron 2000: 86 (1): 52-55.
77. Feather SA, Malcolm S, Woolf AS et al. Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet 2000: 66 (4): 1420-1425.
78. Sanna-Cherchi S, Reese A, Hensle T et al. Familial vesicoureteral reflux: Testing replication of linkage in seven new multigenerational kindreds. J Am Soc Nephrol 2005.
79. Bois E, Feingold J, Benmaiz H et al. Congenital urinary tract malformations: Epidemiologic and genetic aspects. Clin Genet 1975: 8 (1): 37-47.
80. Ardissino G, Dacco V, Testa S et al. Epidemiology of chronic renal failure in children: Data from the ItalKid project. Pediatrics 2003: 111 (4 Pt 1): E382-387.
81. Kong XT, Deng FM, Hu P et al. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol 2004: 167 (6): 1195-1204.
82. Hu P, Deng FM, Liang FX et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 2000: 151 (5): 961-972.
83. Yu OH, Murawski IJ, Myburgh DB et al. Overexpression of RET leads to vesicoureteric reflux in mice. Am J Physiol Renal Physiol 2004: 287 (6): F1123-F1130.
84. Murawski IJ, Myburgh DB, Guay-Woodford LM et al. Ureteric bud position is associated with vesicoureteral reflux and renal malformations in mice. J Am Soc Nephrol 2005.
85. Nishimura H, Yerkes E, Hohenfellner K et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999: 3 (1): 1-10.
86. Srinivas S, Wu Z, Chen CM et al. Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development 1999: 126 (7): 1375-1386.
87. Lore F, Talidis F, Di Cairano G et al. Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations. J Intern Med 2001: 250 (1): 37-42.
88. McGaughran AP, Luo Y, Celli J, Seri M, Donnai D. Hirschsprun's disease and unilateral renal agenesis in a child with RET-protooncogene abnormality. Eur J Hum Genet 1996: 4 (1): 69.
89. Shefelbine SE, Khorana S, Schultz PN et al. Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux. Hum Genet 1998: 102 (4): 474-478.
90. Mouriquand PD, Whitten M, Pracros JP. Pathophysiology, diagnosis and management of prenatal upper tract dilatation. Prenat Diagn 2001: 21 (11): 942-951
91. Favor J, Sandulache R, Neuhauser-Klaus A et al. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci USA 1996: 93 (24): 13870-13875.
92. Mannen H, Tsuji S, Goto N. Incomplete protection mechanism against vesico-ureteral reflux and hydronephrosis in the inbred mouse strain DDD. Lab Anim 1991: 25 (2): 156-161.
93. Porteous S, Torban E, Cho NP et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: Evidence of increased apoptosis in fetal kidneys of Pax2 (1Neu) +/- mutant mice. Hum Mol Genet 2000: 9 (1): 1-11.
94. Miyazaki Y, Oshima K, Fogo A et al. Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int 2003: 63 (3): 835-844.
95. Xu PX, Adams J, Peters H et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999: 23 (1): 113-117.
96. Yerkes E, Nishimura H, Miyazaki Y et al. Role of angiotensin in the congenital anomalies of the kidney and urinary tract in the mouse and the human. Kidney Int Suppl 1998: 67: S75-S77.
97. Yu J, Carroll TJ, McMahon AP. Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 2002: 129 (22): 5301-5312.
98. Chang CP, McDill BW, Neilson JR et al. Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 2004: 113 (7): 1051-1058.
99. Hohenfellner K, Hunley TE, Yerkes E et al. Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux. BJU Int 1999: 83 (3): 318-322.
100. Yoneda A, Cascio S, Green A et al. Angiotensin II type 2 receptor gene is not responsible for familial vesicoureteral reflux. J Urol 2002: 168 (3): 1138-1141.
101. Hiraoka M, Taniguchi T, Nakai H et al. No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int 2001: 59 (4): 1244-1249.
102. Nakano T, Niimura F, Hohenfellner K et al. Screening for mutations in BMP4 and FOXC1 genes in congenital anomalies of the kidney and urinary tract in humans. Tokai J Exp Clin Med 2003: 28 (3): 121-126.
103. Zagradisnik B, Bracic K, Varda NM et al. G-protein beta3 subunit gene C825T polymorphism in patients with vesico-ureteric reflux. Ann Genet 2004: 47 (3): 209-216.
104. Lee-Chen GJ, Liu KP, Lai YC et al. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int 2004: 65 (4): 1467-1472.
105. Andreu N, Escarceller M, Feather S et al. PALML, a novel paralemmin-related gene mapping on human chromosome 1p21. Gene 2001: 278 (1-2): 33-40.
106. Kelly H, Ennis S, Yoneda A et al. Uroplakin III is not a major candidate gene for primary vesicoureteral reflux. Eur J Hum Genet 2005: 13 (4): 500-502.
107. Giltay JC, van de Meerakker J, van Amstel HK et al. No pathogenic mutations in the uroplakin III gene of 25 patients with primary vesicoureteral reflux. J Urol 2004: 171 (2 Pt 1): 931-932.
108. Jiang S, Gitlin J, Deng FM et al. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: Implications for disease heterogeneity. Kidney Int 2004: 66 (1): 10-19.
109. Moerman P, Fryns JP, Sastrowijoto SH et al. Hereditary renal adysplasia: new observations and hypotheses. Pediatr Pathol 1994: 14 (3): 405-410
110. Gorinati M, Zamboni G, Padoin N et al. Terminal deletion of the long arm of chromosome 10: Case report and review of the literature. Am J Med Genet 1989: 33 (4): 502-504.
111. Ogata T, Muroya K, Sasagawa I et al. Genetic evidence for a novel gene(s) involved in urogenital development on 10q26. Kidney Int 2000: 58 (6): 2281-2290.
112. Anderson NG, Abbott GD, Mogridge N et al. Vesicoureteric reflux in the newborn: Relationship to fetal renal pelvic diameter. Pediatr Nephrol 1997: 11 (5): 610-616.
113. Duke V, Quinton R, Gordon I et al. Proteinuria, hypertension and chronic renal failure in X-linked Kallmann's syndrome, a defined genetic cause of solitary functioning kidney. Nephrol Dial Transplant 1998: 13 (8): 1998-2003.